Home

The Leukemia Research Group (LRG)

Group picture

The Leukaemia Research Group is headed by Professor MD Håkon Reikvam.

The research has a major focus on the hematological malignancy acute myeloid leukaemia (AML); an aggressive disease that can be cured only by intensive chemotherapy eventually in combination with stem cell transplantation. Our main research areas are:

  • Biological and functional characterization of primary human AML cells and their interactions with stromal elements
  • Experimental studies of efficiency and toxicity (especially immunotoxicity) of both new targeted therapies and already established therapeutic strategies in human AML.

 

 

News
Øystein Bruserud receives research prize from Helse Vest for his achievments in the field of AML research

Øystein Bruserud receives research prize from Helse Vest for his achievments in the field of AML research

Through his work, Bruserud has contributed considerably in the field of hematological research. His commitment has created the foundation for research activity on AML, on a high national and international level, in the Helse Vest region.

Collaborators

Key collaborators at the University of Bergen:

Researcher Kjell Petersen, CBU Service Group

Professor Frode Berven, Institute of Biomedicine

Professor Bjørn Tore Gjertsen, Institute of Clinical Science

Professor Lars Herfindal, Institute of Clinical Science

 

Key collaborators at Haukeland University Hospital:

Associate Professor Randi Hovland, Department of Medical Genetics, Haukeland University Hospital

Researcher Annette K. Brenner

Consultant Tor Henrik Anderson Tvedt, Department of Medicine, Section of Hematology

 

External collaborators:

Professor Jerome Tamburini, University of Geneva, Switzerland.

Professor Kristian Koenecke, University of Hannover, Germany.

Professor Guro Lind, The Norwegian Cancer Hospital, University of Oslo, Norway.

Professor Tobias Gedde-Dahl, The National Hospital, University of Oslo, Norway.

Professor Stefan Rose-John, University of Kiel, Germany.

 

Funding:

University of Bergen

Norwegian Cancer Society

Helse Vest

Haukeland University Hospital

Norsk indremedisinsk forening

Caroline Musæus Aarsvolds fond

Rakel og Otto Kr. Bruuns legat

Øyvinn Mølbach-Petersen fond

 

 

Sponsors